Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results

v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008

v15i1: pp. 93-104 David Boyd; Thomas R. Ireland Antitrust 2008
Comment: The Valuation of the loss of future pension income
1 × $25.00
Justifying utilization of the total offset method: An opposing comment
1 × $25.00
Valuing the marital portion in defined benefit plans in dissolution cases consistent with the concept of community property
1 × $25.00
A Comment on the Albrecht Review of the Three Arguments Used to Justify Including a Risk-Premium in the Discount Factor
1 × $25.00
The ‘‘Loss of Chance’’ Rule as a Special Category of Damages in Medical Malpractice: A State-by-State Analysis
1 × $25.00
Comment: Confusion about "inflation risk"
1 × $25.00
A Markov process model of work-life expectancies based on labor market activity in 1994-1995
1 × $25.00
Solving the Problem of Points with a Recursion
1 × $25.00 Subtotal: $200.00